【摘要】 乙型肝炎（乙肝）流行是重要的公共卫生问题，其疾病负担重。在我国，乙型肝炎的诊断率和治疗率与世界卫生组织（World Health Organization,WHO）提出的2030年消除病毒性肝炎公共卫生危害的目标仍有较大差距。为实现WHO和“2030健康中国”规划纲要目标，中华预防医学会组织国内临床、公共卫生和检验等领域专家，在全面回顾国内外相关文献的基础上，经过多轮讨论形成本建议，以实现对成人进行普遍筛查，对乙型肝炎病毒感染者进行评估、治疗和长期随访管理，对未感染者进行乙肝疫苗接种，消除乙型肝炎危害的目标。更多还原

【Abstract】 The prevalence of hepatitis B represents a significant public health concern with a heavy disease burden. In China, there is still a big gap between the current diagnosis and treatment rates of hepatitis B and the goal of eliminating viral hepatitis as a public health threat by 2030 set by the World Health Organization(WHO). In order to achieve the WHO goal and the goal of 2030 Healthy China Outline, the Chinese Preventive Medicine Association organized domestic experts in the fields of clinical medicine, public health and clinical laboratory medicine to develop the Expert Recommendations on Screening, Testing and Management for Hepatitis B Virus Infection in Adults after several rounds of discussion based on comprehensive review of relevant domestic and international guidelines and literatures, the purpose is to facilitate universal screening of hepatitis B virus(HBV) infection in adults and provide practical guidance on disease assessment, treatment and long-term follow-up management of people infected with HBV and vaccination for people susceptible to HBV infection, thus promoting the elimination of the threat of hepatitis B.更多还原